Novo Nordisk readies trial results for next-generation weight-loss drug
The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...
Wall Street Journal on MSN7h
Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready to Meet Demand?
Pharmaceutical companies are typically rewarded for their innovation with years of market exclusivity before cheaper generics ...
If You Bought 1 Share of Eli Lilly in 1984, Here's How Many Shares You Would Own Now
The drugmaker Ely Lilly ( LLY -4.93%) has had a very successful run over the long run. Shares currently trade around $818 and are up 20,030% over the past 40 years. The stock has also performed well ...
Medpage Today on MSN22h
Tirzepatide Officially Puts GLP-1 Meds on the Map for Obesity-Related Heart Failure
CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...
pharmaphorum20h
Growing pains: how the pharmaceutical industry can hire and retain talent during industry boom
Looking to the year ahead, here are some key challenges and solutions to keep in mind for a successful 2023 for recruiting, hiring, and retaining talent within a pharmaceutical company.